160 related articles for article (PubMed ID: 1691494)
1. "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin.
Smoller BR; Krueger J; McNutt NS; Hsu A
Mod Pathol; 1990 Mar; 3(2):171-5. PubMed ID: 1691494
[TBL] [Abstract][Full Text] [Related]
2. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes.
Gray MH; Smoller BS; McNutt NS
Am J Dermatopathol; 1991 Oct; 13(5):438-44. PubMed ID: 1719839
[TBL] [Abstract][Full Text] [Related]
4. Immunologic detection of markers of keratinocyte differentiation. Its use in neoplastic and preneoplastic lesions of skin.
Kvedar JC; Fewkes J; Baden HP
Arch Pathol Lab Med; 1986 Mar; 110(3):183-8. PubMed ID: 2418804
[TBL] [Abstract][Full Text] [Related]
5. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
6. Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study.
Tucci MG; Offidani A; Lucarini G; Simonelli L; Amati S; Cellini A; Biagini G; Ricotti G
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):118-24. PubMed ID: 9553907
[TBL] [Abstract][Full Text] [Related]
7. Activated keratinocytes in the epidermis of hypertrophic scars.
Machesney M; Tidman N; Waseem A; Kirby L; Leigh I
Am J Pathol; 1998 May; 152(5):1133-41. PubMed ID: 9588880
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin.
Hodges A; Smoller BR
Mod Pathol; 2002 Nov; 15(11):1121-5. PubMed ID: 12429789
[TBL] [Abstract][Full Text] [Related]
9. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
Satchell AC; Barnetson RS; Halliday GM
Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
11. A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas.
Samuel J; Noujaim AA; Willans DJ; Brzezinska GS; Haines DM; Longenecker BM
Cancer Res; 1989 May; 49(9):2465-70. PubMed ID: 2468409
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis is squamous cell carcinoma.
Lober BA; Lober CW
South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948
[TBL] [Abstract][Full Text] [Related]
13. Keratin and involucrin in preneoplastic and neoplastic lesions. Distribution in the nasal mucosa of nickel workers.
Klein-Szanto AJ; Boysen M; Reith A
Arch Pathol Lab Med; 1987 Nov; 111(11):1057-61. PubMed ID: 2444190
[TBL] [Abstract][Full Text] [Related]
14. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299
[TBL] [Abstract][Full Text] [Related]
16. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.
Hu L; Crowe DL; Rheinwald JG; Chambon P; Gudas LJ
Cancer Res; 1991 Aug; 51(15):3972-81. PubMed ID: 1713123
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
19. p53-binding proteins in squamous cell carcinoma and normal human keratinocytes.
Kumar MG; Spandau DF
Cell Growth Differ; 1995 Dec; 6(12):1601-8. PubMed ID: 9019165
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]